In the BioHarmony Drug Report Database
Testolactone
Teslac (testolactone) is a small molecule pharmaceutical. Testolactone was first approved as Teslac on 1982-01-01. It is used to treat breast neoplasms in the USA. The pharmaceutical is active against aromatase.
Trade Name
|
Teslac |
|---|---|
Common Name
|
testolactone |
ChEMBL ID
|
CHEMBL1571 |
Indication
|
breast neoplasms |
Drug Class
|
Aromatase inhibitor; Antiestrogen |
Image (chem structure or protein)